Evidence map›Paper›PMID 42400480›Full record

ArticleMicrobiology spectrum2026

Metabolomics profiling reveals changes in peptidoglycan and redox metabolism between ancient and modern

Ashleigh Cheyne, Elisabeth V Oskoui, Agnieszka Broda, Nitya Krishnan, Yi Liu, Brian D Robertson, Myrsini Kaforou, Gerald Larrouy-Maumus

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ashleigh Cheyne *Centre for Bacterial Resistance Biology, Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, United Kingdom.
Elisabeth V Oskoui *Centre for Bacterial Resistance Biology, Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, United Kingdom.
Agnieszka BrodaCentre for Bacterial Resistance Biology, Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, United Kingdom.
Nitya KrishnanDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Yi LiuCentre for Bacterial Resistance Biology, Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, United Kingdom.
Brian D RobertsonDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Myrsini KaforouDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Gerald Larrouy-MaumusCentre for Bacterial Resistance Biology, Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, United Kingdom.ORCID 0000-0001-6614-8698

Funding

Medical Research Council MR/W018756/1Wellcome TrustWellcome Trust 206508/Z/17/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mycobacterium tuberculosisPeptidoglycanAmino AcidsErgothioneineHumansMetabolomeMetabolomicsOxidation-ReductionTuberculosisAmino AcidsErgothioneinePeptidoglycanlineagesmetabolomicstuberculosis

Identifiers

PMID42400480
PMCPMC13436370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.